Postoperative or Postradiation Adjuvant Androgen Deprivation Therapy in Locally Advanced Prostate Cancer (High and Very High Risk) Patients
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Non-Interventional Study PREVENT (NCT02155998) | AstraZeneca | 2014-07-16 |
Track Postoperative or Postradiation Adjuvant Androgen Deprivation Therapy in Locally Advanced Prostate Cancer (High and Very High Risk) Patients automatically
Every clearance here is in the API, with alerts when new ones post.